/People

Jason Pontin

Investor

General Partner at DCVC (Data Collective)

Palo Alto, California

Writes $5M – $25M checks · typically $15M

Find your path to Jason

Sign up to see every warm intro you have to Jason

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jason. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Jason Pontin is a General Partner at DCVC focused on early-stage computational biology and chemistry startups, having joined in 2021 after serving as Senior Partner at Flagship Pioneering. He cofounded Totus Medicines and previously ran media companies, serving as Editor in Chief and Publisher of MIT Technology Review from 2004 to 2017.

Contact· published on Jason's own website

Invests in

AI & Machine LearningBiotechClimate Tech

Beyond investing

Founded
Pontin founded The Acumen Journal, a magazine about the life sciences. Pontin cofounded MIT Solve in 2015, the institute's open innovation platform. Pontin cofounded Totus Medicines in 2019 with CEO Neil Dhawan.
Education
Studied at Harrow School Studied at Keble College, Oxford
Communities
Pontin delivered a 2013 TED Talk in Long Beach, California titled 'Can Technology solve our big problems?'
Family
Pontin was born in London to a British father, Anthony Charles Pontin, a businessman, and a South African mother, Elaine Howells, an actress.
More
Pontin writes for Wired in the publication's 'IDEAS' channel.

Mentioned above: the Harrow School mafia →

From Jason's own website — common ground for a warm intro.

Deals · 3

Proxima BioBoard seat

via DCVC (Data Collective) · filed Jun 2026 · $91.5M raise

TatioBoard seat

via DCVC (Data Collective) · filed Nov 2022 · $2.5M raise

ZwitterCoBoard seat

via DCVC (Data Collective) · filed May 2022 · $33.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources · the firm's website.

Colleagues at DCVC (Data Collective)

Network6

Investors connected to Jason in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jason Pontin?
Jason Pontin is a General Partner at DCVC focused on early-stage computational biology and chemistry startups, having joined in 2021 after serving as Senior Partner at Flagship Pioneering. He cofounded Totus Medicines and previously ran media companies, serving as Editor in Chief and Publisher of MIT Technology Review from 2004 to 2017.
Where does Jason Pontin work?
Jason Pontin is General Partner at DCVC (Data Collective).
What does Jason Pontin invest in?
Jason Pontin invests in AI & Machine Learning, Biotech, Climate Tech.
What check size does Jason Pontin write?
Jason Pontin typically writes checks of $5M – $25M.
What boards does Jason Pontin sit on?
Jason Pontin holds tracked board seats at Kanvas Bio, Proxima Bio, Relation Therapeutics, Tatio, Totus Medicines, ZwitterCo.
What companies has Jason Pontin invested in?
Investments tracked here include Aclarity, Aquafortus, Callosum, Kanvas Bio, Relation Therapeutics, Totus Medicines, VantAI, Inc., ZwitterCo.

Founder mafias

About this profile. Compiled from public sources — DCVC (Data Collective)'s own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights